vs
Axogen, Inc.(AXGN)与READING INTERNATIONAL INC(RDI)财务数据对比。点击上方公司名可切换其他公司
Axogen, Inc.的季度营收约是READING INTERNATIONAL INC的1.2倍($61.5M vs $50.3M),READING INTERNATIONAL INC净利率更高(-5.1% vs -31.9%,领先26.8%),Axogen, Inc.同比增速更快(26.6% vs -14.2%),READING INTERNATIONAL INC自由现金流更多($4.1M vs $-1.4M),过去两年Axogen, Inc.的营收复合增速更高(13.3% vs 5.6%)
Axogen总部位于美国佛罗里达州阿拉楚阿,是外科解决方案提供商,专注开发周围神经损伤修复相关产品,涵盖人体组织移植物、神经连接器、软组织膜等,旗下AVANCE细胞移植技术可模拟人体神经结构,临床数据显示其产品帮助87%的周围神经损伤患者实现感觉与运动功能恢复,2013年完成1800万美元首次公开募股。
雷丁公司是总部位于美国费城的铁路企业,1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务,直至1976年被联合铁路公司收购。
AXGN vs RDI — 直观对比
营收规模更大
AXGN
是对方的1.2倍
$50.3M
营收增速更快
AXGN
高出40.7%
-14.2%
净利率更高
RDI
高出26.8%
-31.9%
自由现金流更多
RDI
多$5.5M
$-1.4M
两年增速更快
AXGN
近两年复合增速
5.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $61.5M | $50.3M |
| 净利润 | $-19.6M | $-2.6M |
| 毛利率 | 75.2% | — |
| 营业利润率 | 20.2% | -1.9% |
| 净利率 | -31.9% | -5.1% |
| 营收同比 | 26.6% | -14.2% |
| 净利润同比 | -410.8% | -14.5% |
| 每股收益(稀释后) | $-0.38 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AXGN
RDI
| Q1 26 | $61.5M | — | ||
| Q4 25 | $59.9M | $50.3M | ||
| Q3 25 | $60.1M | $52.2M | ||
| Q2 25 | $56.7M | $60.4M | ||
| Q1 25 | $48.6M | $40.2M | ||
| Q4 24 | $49.4M | $58.6M | ||
| Q3 24 | $48.6M | $60.1M | ||
| Q2 24 | $47.9M | $46.8M |
净利润
AXGN
RDI
| Q1 26 | $-19.6M | — | ||
| Q4 25 | $-13.2M | $-2.6M | ||
| Q3 25 | $708.0K | $-4.2M | ||
| Q2 25 | $579.0K | $-2.7M | ||
| Q1 25 | $-3.8M | $-4.8M | ||
| Q4 24 | $450.0K | $-2.2M | ||
| Q3 24 | $-1.9M | $-7.0M | ||
| Q2 24 | $-1.9M | $-12.8M |
毛利率
AXGN
RDI
| Q1 26 | 75.2% | — | ||
| Q4 25 | 74.1% | — | ||
| Q3 25 | 76.6% | — | ||
| Q2 25 | 74.2% | — | ||
| Q1 25 | 71.9% | — | ||
| Q4 24 | 76.1% | — | ||
| Q3 24 | 74.9% | — | ||
| Q2 24 | 73.8% | — |
营业利润率
AXGN
RDI
| Q1 26 | 20.2% | — | ||
| Q4 25 | -16.3% | -1.9% | ||
| Q3 25 | 3.2% | -0.6% | ||
| Q2 25 | 3.0% | 4.8% | ||
| Q1 25 | -3.4% | -17.2% | ||
| Q4 24 | 4.1% | 2.6% | ||
| Q3 24 | -0.6% | -0.6% | ||
| Q2 24 | -0.9% | -16.4% |
净利率
AXGN
RDI
| Q1 26 | -31.9% | — | ||
| Q4 25 | -22.0% | -5.1% | ||
| Q3 25 | 1.2% | -8.0% | ||
| Q2 25 | 1.0% | -4.4% | ||
| Q1 25 | -7.9% | -11.8% | ||
| Q4 24 | 0.9% | -3.8% | ||
| Q3 24 | -3.8% | -11.7% | ||
| Q2 24 | -4.0% | -27.4% |
每股收益(稀释后)
AXGN
RDI
| Q1 26 | $-0.38 | — | ||
| Q4 25 | $-0.28 | $-0.11 | ||
| Q3 25 | $0.01 | $-0.18 | ||
| Q2 25 | $0.01 | $-0.12 | ||
| Q1 25 | $-0.08 | $-0.21 | ||
| Q4 24 | $-0.00 | $-0.11 | ||
| Q3 24 | $-0.04 | $-0.31 | ||
| Q2 24 | $-0.04 | $-0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $82.7M | $10.5M |
| 总债务越低越好 | — | $185.1M |
| 股东权益账面价值 | $244.8M | $-18.2M |
| 总资产 | $289.5M | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
AXGN
RDI
| Q1 26 | $82.7M | — | ||
| Q4 25 | $41.5M | $10.5M | ||
| Q3 25 | $35.8M | $8.1M | ||
| Q2 25 | $29.9M | $9.1M | ||
| Q1 25 | $22.1M | $5.9M | ||
| Q4 24 | $33.5M | $12.4M | ||
| Q3 24 | $24.5M | $10.1M | ||
| Q2 24 | $21.1M | $9.3M |
总债务
AXGN
RDI
| Q1 26 | — | — | ||
| Q4 25 | $48.4M | $185.1M | ||
| Q3 25 | $48.2M | — | ||
| Q2 25 | $47.9M | — | ||
| Q1 25 | $47.7M | — | ||
| Q4 24 | $47.5M | $202.7M | ||
| Q3 24 | $47.3M | — | ||
| Q2 24 | $47.0M | — |
股东权益
AXGN
RDI
| Q1 26 | $244.8M | — | ||
| Q4 25 | $128.8M | $-18.2M | ||
| Q3 25 | $120.8M | $-12.1M | ||
| Q2 25 | $112.3M | $-7.7M | ||
| Q1 25 | $105.4M | $-8.1M | ||
| Q4 24 | $103.9M | $-4.4M | ||
| Q3 24 | $99.4M | $1.6M | ||
| Q2 24 | $95.7M | $6.5M |
总资产
AXGN
RDI
| Q1 26 | $289.5M | — | ||
| Q4 25 | $221.7M | $434.9M | ||
| Q3 25 | $216.4M | $435.2M | ||
| Q2 25 | $205.5M | $438.1M | ||
| Q1 25 | $196.2M | $441.0M | ||
| Q4 24 | $203.7M | $471.0M | ||
| Q3 24 | $192.0M | $495.7M | ||
| Q2 24 | $188.9M | $494.9M |
负债/权益比
AXGN
RDI
| Q1 26 | — | — | ||
| Q4 25 | 0.38× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.45× | — | ||
| Q4 24 | 0.46× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.49× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $4.3M |
| 自由现金流经营现金流 - 资本支出 | $-1.4M | $4.1M |
| 自由现金流率自由现金流/营收 | -2.3% | 8.2% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $9.1M | $-2.9M |
8季度趋势,按日历期对齐
经营现金流
AXGN
RDI
| Q1 26 | — | — | ||
| Q4 25 | $3.0M | $4.3M | ||
| Q3 25 | $3.2M | $295.0K | ||
| Q2 25 | $7.7M | $1.6M | ||
| Q1 25 | $-13.2M | $-7.7M | ||
| Q4 24 | $8.7M | $8.0M | ||
| Q3 24 | $3.9M | $1.3M | ||
| Q2 24 | $4.2M | $-10.4M |
自由现金流
AXGN
RDI
| Q1 26 | $-1.4M | — | ||
| Q4 25 | $1.8M | $4.1M | ||
| Q3 25 | $1.7M | $-246.0K | ||
| Q2 25 | $7.0M | $1.2M | ||
| Q1 25 | $-13.4M | $-8.0M | ||
| Q4 24 | $8.1M | $7.0M | ||
| Q3 24 | $3.3M | $-1.1M | ||
| Q2 24 | $3.3M | $-10.6M |
自由现金流率
AXGN
RDI
| Q1 26 | -2.3% | — | ||
| Q4 25 | 3.0% | 8.2% | ||
| Q3 25 | 2.8% | -0.5% | ||
| Q2 25 | 12.4% | 1.9% | ||
| Q1 25 | -27.7% | -19.8% | ||
| Q4 24 | 16.3% | 12.0% | ||
| Q3 24 | 6.8% | -1.8% | ||
| Q2 24 | 6.8% | -22.7% |
资本支出强度
AXGN
RDI
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 0.3% | ||
| Q3 25 | 2.5% | 1.0% | ||
| Q2 25 | 1.3% | 0.6% | ||
| Q1 25 | 0.5% | 0.6% | ||
| Q4 24 | 1.4% | 1.7% | ||
| Q3 24 | 1.2% | 4.0% | ||
| Q2 24 | 1.9% | 0.5% |
现金转化率
AXGN
RDI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 4.55× | — | ||
| Q2 25 | 13.35× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 19.41× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXGN
暂无分部数据
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |